New York Life Investment Management LLC Amphastar Pharmaceuticals, Inc. Transaction History

New York Life Investment Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 05, 2024	SELL	$44.49 - $62.93 $10,455 - $14,788	-235 Reduced 2.48%	9,245 $571,000
Q3 2023 Nov 07, 2023	SELL	$45.51 - $65.0 $68,720 - $98,150	-1,510 Reduced 13.74%	9,480 $435,000
Q2 2023 Aug 04, 2023	SELL	$35.77 - $58.38 $56,910 - $92,882	-1,591 Reduced 12.65%	10,990 $631,000
Q1 2023 May 08, 2023	SELL	$27.99 - $37.92 $89,008 - $120,585	-3,180 Reduced 20.18%	12,581 $471,000
Q4 2022 Feb 10, 2023	BUY	$27.93 - $31.27 $48,626 - $54,441	1,741 Added 12.42%	15,761 $441,000
Q3 2022 Nov 10, 2022	BUY	$27.56 - $37.75 $28,386 - $38,882	1,030 Added 7.93%	14,020 $394,000
Q2 2022 Aug 12, 2022	BUY	$29.79 - $42.29 $386,972 - $549,347	12,990 New	12,990 $452,000

286

34.9M

74.3K

22.3K

Ticker AMPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,015,200
Market Cap $1.92B
Description
Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...

Get notified when there are updates to the investment portfolio of New York Life Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on New York Life Investment Management LLC with notifications on news.